ArticleGels (Basel, Switzerland)2026
Curdlan-Reinforced Chitosan/Polyacrylate Interpenetrating Hydrogels with Enhanced Mechanical Stability for Gastric Retention and pH-Responsive Drug Release.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Polysaccharide-based hydrogels for gastric retention face the inherent challenge of achieving effective retention through swelling while avoiding mechanical failure. Here, we introduce a strategy by incorporating curdlan into chitosan/sodium polyacrylate interpenetrating networks to reinforce the hydrogel and regulate swelling-induced transport behavior. Curdlan-reinforced chitosan/polyacrylate (CS/CUR/PAAS) hydrogels with varying curdlan content (0-4 wt.%) were synthesized and characterized. Optimal reinforcement was achieved with 2 wt.% curdlan, yielding an indentation hardness of ~80 kPa and an elastic modulus of ~63 kPa without compromising swelling capacity. Under acidic conditions (pH 1.2), the hydrogel swelled rapidly (~50-fold at 3 h; ~140-fold at 8 h) while maintaining structural integrity. Using a dynamic in vitro human stomach simulator (DHSI-IV), the optimized hydrogel demonstrated gastric retention for up to 5 h, with ~60% of the initial mass retained at 6 h. Metformin hydrochloride release followed diffusion-controlled kinetics (~69% over 8 h), governed primarily by pH with secondary shear modulation. Microstructural and rheological analyses revealed that acidic conditions regulated network expansion, viscoelastic relaxation, and pore formation, which in turn controlled transport pathways and drug release. The findings highlight that curdlan reinforcement stabilizes swelling behavior under acidic conditions, offering a robust and pH-responsive strategy for designing mechanically stable, gastric-retentive hydrogels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.